Form 4 for HCA HCA Healthcare
Accepted 2023-04-26 00:00:00 ET · period of report 2023-04-24 · accession 0001209191-23-025692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-26 | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $101.16 | +32.0K | 60.8K | +111% | +$3.24M |
| D | 2023-04-26 | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $286.25 | -19.5K | 41.3K | -32% | -$5.57M |
| D | 2023-04-26 | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $0.00 | -32.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-24 | M | A | 32,020 | $101.16 | 60,803.36 | D | — | — | (F1) Includes 2,363.3569 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-04-24 | F | D | 19,464 | $286.25 | 41,339.36 | D | — | — | (F1) Includes 2,363.3569 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 3 | Derivative | Stock Appreciation Right | 2023-04-24 | M | D | 32,020 | $0.00 | 0 | D | $101.16 · — to 2028-01-31 | 32,020 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |